When comparing all PRGN-2009–treated mice (n = 8) to PBS-treated controls (n = 8, Table 1, top), total CD8+ T cells per mg of tumor increased greatly, to a 33:1 ratio. This evidence concerns the gene CD8A and neoplasm.